Marshall Wace’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Marshall Wace’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-21,338	Closed	-$362K	–	1067
2014 Q4	$362K	Sell	21,338 -361,883	-94%	-$5.09M	﹤0.01%	688
2014 Q3	$4.57M	Buy	+383,221	New	+$2.62M	0.07%	301

Marshall Wace's AVNR Position: Q1 2015 in Review

Marshall Wace sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 21,338 shares — an estimated $362K sold.

Marshall Wace first reported a position in AVNR in Q3 2014 and held it in 2 quarters. The position peaked at $4.57M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Marshall Wace reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Marshall Wace sold 21,338 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $362K.
Marshall Wace first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 2 quarters.
Marshall Wace's AVANIR PHARMACEUTICALS, INC CL A position peaked at $4.57M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.